Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

  • C. A S Arndt
  • , A. G. Nascimento
  • , G. Schroeder
  • , P. J. Schomberg
  • , J. P. Neglia
  • , S. F. Sencer
  • , T. L. Silberman
  • , C. L. Moertel
  • , J. K. Tillisch
  • , J. S. Miser

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology